0.59
+0.0082(+1.41%)
Currency In USD
| Previous Close | 0.58 |
| Open | 0.59 |
| Day High | 0.6 |
| Day Low | 0.58 |
| 52-Week High | 1.42 |
| 52-Week Low | 0.45 |
| Volume | 1.14M |
| Average Volume | 2.45M |
| Market Cap | 86.48M |
| PE | -2.68 |
| EPS | -0.22 |
| Moving Average 50 Days | 0.56 |
| Moving Average 200 Days | 0.65 |
| Change | 0.01 |
If you invested $1000 in Veru Inc. (VERU) 10 years ago, it would be worth $359.76 as of July 02, 2025 at a share price of $0.59. Whereas If you bought $1000 worth of Veru Inc. (VERU) shares 5 years ago, it would be worth $175.6 as of July 02, 2025 at a share price of $0.59.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Veru to Participate in the Virtual BTIG Obesity Health Forum
GlobeNewswire Inc.
Jun 11, 2025 12:30 PM GMT
MIAMI, FL, June 11, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced the co
Veru Participates in a Virtual Investor KOL Connect Segment
GlobeNewswire Inc.
May 08, 2025 1:25 PM GMT
-- Moderated discussion with preeminent obesity expert, Louis J. Aronne, MD, FACP and Mitchell Steiner, M.D., F.A.C.S, President, CEO, and Founder, of Veru -- MIAMI, FL, May 08, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical sta
Veru to Report Fiscal 2025 Second Quarter Financial Results on May 8
GlobeNewswire Inc.
May 01, 2025 12:30 PM GMT
MIAMI, May 01, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced it will hos